Finance

Lists
Why is NOC up 2.06%?
Dive Deeper
NOC:NYSE
Northrop Grumman Corp
$563.15
+2.06%
(+11.35) 1D
Oct 26, 2:01:15 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NOC...
Open
$553.86
High
$564.24
Low
$553.86
Mkt. cap
80.00B
Avg. vol.
1.04M
Volume
345.86K
Dividend
1.75%
Quarterly dividend
$2.47
Ex-dividend date
Aug 31, 2026
P/E ratio
17.76
52-wk high
$774.00
52-wk low
$470.06
EPS
$31.70
Beta
-0.11
Shares outstanding
142.06M
No. of employees
95K
Open
$553.86
High
$564.24
Low
$553.86
Mkt. cap
80.00B
Avg. vol.
1.04M
Volume
345.86K
Dividend
1.75%
Quarterly dividend
$2.47
Ex-dividend date
Aug 31, 2026
P/E ratio
17.76
52-wk high
$774.00
52-wk low
$470.06
EPS
$31.70
Beta
-0.11
Shares outstanding
142.06M
No. of employees
95K
News stories
From web sources and news partners
Profile
Northrop Grumman Corporation is an American aerospace and defense company that designs and manufactures systems for aeronautics, defense, missions, and space. Headquartered in West Falls Church, Virginia, the company is the fifth-largest contractor of the U.S. federal government; it receives over 2% of all federal government spending on contractors. The company was formed in 1994 through the merger of Northrop Corporation and Grumman Aerospace. It is ranked 110th on the Fortune 500 list of America's largest corporations. In 2024, 87% of the company's revenues came from the US federal government, while 12% was from international sources. Northrop Grumman and its industry partners have won the Collier Trophy nine times, including for the development and production of the James Webb Space Telescope, launched in 2021. Wikipedia
About Northrop Grumman Corp
CEOKathy J. Warden
Employees95K
Founded1939
HeadquartersFalls Church, Virginia, United States
SectorAerospace and Defense
Analyst ratings
Based on 17 analysts giving stock ratings to NOC in the past 3 months
Buy
Buy
10
Hold
6
Sell
1
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for NOC in the last 3 months.
Highest
Current $563.15
$815.00 (+44.72%)
Average
$632.71 (+12.35%)
Lowest
$430.00 (-23.64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Seth Seifman
J.P. Morgan
Hold
Reiterated
$605.00
+7.4%
10/26/2026
Sheila Kahyaoglu
Jefferies
Hold
Maintained
$585.00
+3.9%
10/25/2026
Noah Poponak
Goldman Sachs
Hold
Maintained
$525.00
-6.8%
10/22/2026
Anthony Valentini
Barclays
Sell
Maintained
$430.00
-23.6%
10/22/2026
John Godyn
Citi
Buy
Maintained
$667.00
+18.4%
10/21/2026
Charles Minervino
Susquehanna
Buy
Maintained
$655.00
+16.3%
10/20/2026
Gavin Parsons
UBS
Buy
Reiterated
$698.00
+23.9%
10/21/2026
Peter Arment
Robert W. Baird
Buy
Upgraded
$675.00
+19.9%
10/21/2026
Kristine Liwag
Morgan Stanley
Buy
Reiterated
$765.00
+35.8%
10/21/2026
Kenneth Herbert
RBC Capital
Hold
Maintained
$550.00
-2.3%
10/20/2026
Michael Ciarmoli
Guggenheim
Buy
Reiterated
$640.00
+13.6%
10/20/2026
David E. Strauss
Wells Fargo
Buy
Maintained
$620.00
+10.1%
10/20/2026
Ronald Epstein
Bank of America Securities
Buy
Maintained
$750.00
+33.2%
10/20/2026
Douglas Harned
Bernstein
Hold
Maintained
$556.00
-1.3%
10/14/2026
Gautam Khanna
TD Cowen
Hold
Maintained
$540.00
-4.1%
10/09/2026
Unknown Analyst
Barclays
Sell
Initiated
$419.00
-25.6%
10/08/2026
Margaret Schooley
Rothschild & Co Redburn
Buy
Initiated
$680.00
+20.7%
10/06/2026
Unknown Analyst
Guggenheim
Buy
Initiated
$612.00
+8.7%
09/14/2026
Andre Madrid
BTIG
Buy
Maintained
$815.00
+44.7%
08/03/2026
Kristina Ruggeri
Argus Research
Buy
Reiterated
$700.00
+24.3%
07/23/2026
Scott Deuschle
Deutsche Bank
Buy
Reiterated
$615.00
+9.2%
07/22/2026
Last report
Oct 20, 2026
Fiscal period
Q3 2026
$7.89 / $7.18
+9.89%beat
Revenue / Est. (USD)
11.12B / 11.13B
-0.04%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
11.71B
9.88B
10.88B
11.12B
Cost of goods sold
9.42B
7.92B
8.76B
8.77B
Cost of revenue
9.42B
7.92B
8.76B
8.77B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
360.00M
805.00M
859.00M
916.00M
Operating expense
360.00M
805.00M
859.00M
916.00M
Total operating expenses
9.78B
8.73B
9.61B
9.69B
Operating income
1.94B
1.16B
1.26B
1.44B
Other non operating income
26.00M
37.00M
32.00M
20.00M
EBT including unusual items
1.74B
1.03B
1.17B
1.30B
EBT excluding unusual items
1.79B
1.03B
1.13B
1.30B
Income tax expense
313.00M
155.00M
74.00M
174.00M
Effective tax rate
17.99%
15.05%
6.34%
13.41%
Other operating expenses
-
-
-
-
Net income
1.43B
875.00M
1.09B
1.12B
Net profit margin
12.18%
8.86%
10.06%
10.11%
Earnings per share
7.23
6.14
7.68
7.89
Interest and investment income
-
-
-
-
Interest expense
-175.00M
-162.00M
-161.00M
-158.00M
Net interest expenses
-175.00M
-162.00M
-161.00M
-158.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.34B
1.53B
1.63B
1.82B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps